For LowerRespiratory Tract Infections, Upper Respiratory Tract Infections and Urinary Tract Infections.
Cefpodoxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefpodoxime has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of Gram-negative and Gram-positive bacteria.Clavulanic acid is a beta-lactam structurally related to penicillins. It inactivates beta-lactamase enzymes.
Adults:Pharyngitis and/or tonsillitis- 100 mg every 12 hoursfor 5–10 days,Uncomplicated urinary tract infection-100 mg every 12 hours for 7 days.In children:2months to 12 years: 4-5 mg/kg every 12 hours (Max 200 mg/dose) for 5 – 10 days. Dosage beased on cefpodoxime component.
CefpodoximeProxetil is contraindicated in patients with known hypersensitivity to Cefpodoxime or to the cephalosporin group of antibiotics.
Clostridium difficile-associated diarrhea (CDAD) has been reported with the use of nearly all antibacterial agents, including cefpodoximeproxetil, and may range in severity from mild diarrhoea to fatal colitis.
There are no adequate and well-controlled studies in children below 2 months of age.This product should only be used in pregnancy if considered essential by the physician.Excreted in milk can cause potential for serious reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H2 blockers reduce peak plasma levels of cefpodoxime. Renal excretion of Cefpodoxime was inhibited by probenecid
The side effects include diarrhoea, nausea, skin & vaginal fungal infection, abdominal pain, dyspepsia